Related references
Note: Only part of the references are listed.Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Bhumsuk Keam et al.
BREAST CANCER RESEARCH (2011)
Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification
Cathy B. Moelans et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
Julie M. Wu et al.
HUMAN PATHOLOGY (2010)
Human Epidermal Growth Factor Receptor 2 Testing in 2010: Does Chromosome 17 Centromere Copy Number Make Any Difference?
Jeffrey S. Ross
JOURNAL OF CLINICAL ONCOLOGY (2010)
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
Effect of High Copy Number of HER2 Associated With Polysomy 17 on HER2 Protein Expression in Invasive Breast Carcinoma
Sejal S. Shah et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Be precise! The need to consider the mechanisms for CEP17 copy number changes in breast cancer
Giuseppe Viale
JOURNAL OF PATHOLOGY (2009)
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis
Caterina Marchio et al.
JOURNAL OF PATHOLOGY (2009)
Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma
Uma Krishnamurti et al.
MODERN PATHOLOGY (2009)
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
I-Tien Yeh et al.
MODERN PATHOLOGY (2009)
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
Monica M. Reinholz et al.
LANCET ONCOLOGY (2009)
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
Isabelle Vanden Bempt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER2 status in early breast cancer: Relevance of cell staining patterns, gene amplification and polysomy 17
Rosalba Torrisi et al.
EUROPEAN JOURNAL OF CANCER (2007)
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
Lissandra Dal Lago et al.
MOLECULAR CANCER THERAPEUTICS (2006)
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials
MF Press et al.
CLINICAL CANCER RESEARCH (2005)
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study
E Downs-Kelly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
M Salido et al.
BREAST CANCER RESEARCH (2005)
Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
G Konecny et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Evaluation of HER-2/neu gene amplification and overexpression:: Comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens
MF Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg et al.
ANNALS OF ONCOLOGY (2002)
Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization
F Tsukamoto et al.
CANCER CYTOPATHOLOGY (2001)
Share Paper
